Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 Trial.
Lorenzo GerratanaMasha KocherginskyAndrew A DavisPaolo D'AmicoCarolina ReduzziFabio PuglisiMassimo CristofanilliPublished in: The oncologist (2023)
This study is the first analysis of CTCs modeling for stage IV disease stratification. These results show the need to expand biomarker profiling in combination with CTCs stratification for improved biomarker-driven drug development.